BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38066444)

  • 1. Immediate histologic correlation in patients with different HPV genotypes and ages: a single center analysis in China.
    Kong L; Xiao X; Xu T; Wan R; Chen F
    BMC Cancer; 2023 Dec; 23(1):1211. PubMed ID: 38066444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Human Papillomavirus Genotypes Among Women With High-Grade Cervical Lesions in Beijing, China.
    Xiao M; Xu Q; Li H; Gao H; Bie Y; Zhang Z
    Medicine (Baltimore); 2016 Jan; 95(3):e2555. PubMed ID: 26817906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status].
    Luo HX; Du H; Liu ZH; Zhang LJ; Wang C; Wu RF
    Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):232-238. PubMed ID: 29575846
    [No Abstract]   [Full Text] [Related]  

  • 4. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
    Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
    Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of extended human papillomavirus genotyping and multiple infections in early detection of cervical precancer and cancer and HPV vaccination.
    Song F; Yan P; Huang X; Wang C; Du H; Qu X; Wu R
    BMC Cancer; 2022 Jan; 22(1):42. PubMed ID: 34991494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FAM19A4/miR124-2 Methylation Testing and Human Papillomavirus (HPV) 16/18 Genotyping in HPV-Positive Women Under the Age of 30 Years.
    Vink FJ; Meijer CJLM; Hesselink AT; Floore AN; Lissenberg-Witte BI; Bonde JH; Pedersen H; Cuschieri K; Bhatia R; Poljak M; Oštrbenk Valenčak A; Hillemanns P; Quint WGV; Del Pino M; Kenter GG; Steenbergen RDM; Heideman DAM; Bleeker MCG
    Clin Infect Dis; 2023 Feb; 76(3):e827-e834. PubMed ID: 35686306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical utility of extended high-risk HPV genotyping in risk-stratifying women with L-SIL cytology: A retrospective study of 8726 cases.
    Tao X; Zhang H; Zhang H; Xiao Y; Zhong F; Zhou X; Cong Q; Sui L; Zhao C
    Cancer Cytopathol; 2022 Jul; 130(7):542-550. PubMed ID: 35312217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of HPV16 and high-grade cytology in women undergoing active surveillance for cervical intraepithelial neoplasia grade 2.
    Damgaard RK; Jenkins D; Stoler MH; van de Sandt MM; Lycke KD; de Koning MNC; Quint WGV; Steiniche T; Petersen LK; Hammer A
    Acta Obstet Gynecol Scand; 2023 Sep; 102(9):1227-1235. PubMed ID: 37469102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotype, cervical intraepithelial neoplasia, and type-specific cervical intraepithelial neoplasia distributions in hrHPV+ cases referred to colposcopy: A multicenter study of Chinese mainland women.
    Chen M; Ye Z; Wang H; Cui X; Seery S; Wu A; Xue P; Qiao Y
    J Med Virol; 2024 Mar; 96(3):e29475. PubMed ID: 38415472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus genotypes in cervical intraepithelial neoplasia grade 3.
    Castle PE; Schiffman M; Wheeler CM; Wentzensen N; Gravitt PE
    Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1675-81. PubMed ID: 20615885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining hrHPV genotypes in cervical intraepithelial neoplasia by laser capture microdissection supports reflex triage of self-samples using HPV16/18 and FAM19A4/miR124-2 methylation.
    Leeman A; Ebisch RMF; Kasius A; Bosgraaf RP; Jenkins D; van de Sandt MM; de Strooper LMA; Heideman DAM; Snijders PJF; Massuger LFAG; Bekkers RLM; Meijer CJLM; van Kemenade FJ; Quint WGV; Melchers WJG
    Gynecol Oncol; 2018 Nov; 151(2):311-318. PubMed ID: 30219239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus in invasive cervical cancer and cervical intraepithelial neoplasia 2 and 3 in Venezuela: a cross-sectional study.
    Sánchez-Lander J; Cortiñas P; Loureiro CL; Pujol FH; Medina F; Capote-Negrín L; Bianchi G; García-Barriola V; Ruiz-Benni A; Avilán-Rovira J; Acosta H
    Cancer Epidemiol; 2012 Oct; 36(5):e284-7. PubMed ID: 22608058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus infections among women with cervical lesions and cervical cancer in Yueyang, China: a cross-sectional study of 3674 women from 2019 to 2022.
    Zeng M; Zhang X; He L; Liu X; Liu H; Deng R; Qiu B; Liu F; Xiao H; Li Q; Li W; Liu C; Ge Y
    Virol J; 2023 Nov; 20(1):254. PubMed ID: 37919730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada.
    Coutlée F; Ratnam S; Ramanakumar AV; Insinga RR; Bentley J; Escott N; Ghatage P; Koushik A; Ferenczy A; Franco EL
    J Med Virol; 2011 Jun; 83(6):1034-41. PubMed ID: 21503917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk stratification for cervical precancer and cancer by DH3-HPV partial genotyping and cytology in women attending cervical screening: A retrospective cohort study.
    Fu Y; Li Y; Li X; Wang X; Lü W
    J Med Virol; 2023 Feb; 95(2):e28482. PubMed ID: 36609841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stratified risk of high-grade cervical disease using onclarity HPV extended genotyping in women, ≥25 years of age, with NILM cytology.
    Stoler MH; Wright TC; Parvu V; Yanson K; Cooper CK; Andrews J
    Gynecol Oncol; 2019 Apr; 153(1):26-33. PubMed ID: 30638767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensive HPV Genotyping Reveals High Association between Multiple Infections and Cervical Lesions in Chinese Women.
    Zhong F; Yu T; Ma X; Wang S; Cong Q; Tao X
    Dis Markers; 2022; 2022():8130373. PubMed ID: 35722626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-infections of HPV16/18 with other high-risk HPV types and the risk of cervical carcinogenesis: A large population-based study.
    Wu P; Xiong H; Yang M; Li L; Wu P; Lazare C; Cao C; Gao P; Meng Y; Zhi W; Lin S; Hu J; Wei J; Ma D; Liu J; Yin P; Xing H
    Gynecol Oncol; 2019 Dec; 155(3):436-443. PubMed ID: 31604662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of Single Versus Multiple Human Papillomavirus Infections With the Prevalence of Cervical Intraepithelial Neoplasia 2/3 and Squamous Cell Carcinoma Lesions: Human Papillomavirus Type-Specific Attribution.
    Zhong F; Wang T; Li W; Zhang H; Zeng X; Geisler D; Zhou X; Cong Q; Sui L; Tao X; Zhao C
    Lab Invest; 2024 Apr; 104(4):100328. PubMed ID: 38237737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in genotype prevalence of human papillomavirus over 10-year follow-up of a cervical cancer screening cohort].
    Dong L; Hu SY; Zhang Q; Feng RM; Zhang L; Zhao XL; Ma JF; Shi SD; Zhang X; Pan QJ; Zhang WH; Qiao YL; Zhao FH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jan; 38(1):20-25. PubMed ID: 28100371
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.